Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 Welch Rd
Palo Alto, CA 94304Phone+1 650-497-8000
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1999 - 2002
Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1997 - 1999
Columbia University Vagelos College of Physicians and SurgeonsClass of 1997
Certifications & Licensure
CA State Medical License 1998 - 2016
Clinical Trials
- A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL Start of enrollment: 2017 Oct 31
Publications & Presentations
PubMed
- 278 citationsRevisiting Human IL-12Rβ1 Deficiency: A Survey of 141 Patients From 30 CountriesLudovic de Beaucoudrey, Arina Samarina, Jacinta Bustamante, Aurélie Cobat, Stéphanie Boisson-Dupuis
Medicine. 2010-11-01 - 73 citationsZanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletionConstantine S. Tam, Tadeusz Robak, Paolo Ghia, Brad S. Kahl, Patricia F. Walker
Haematologica. 2020-10-13 - 31 citationsZanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single...Mazyar Shadman, Ian W Flinn, Moshe Y Levy, Ryan F Porter, John M Burke
The Lancet. Haematology. 2023-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
